Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.12.2018 | Case report

Antineoplastics

Various toxicities: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Guan J, et al. Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib. Cold Spring Harbor Molecular Case Studies 4: a002550, No. 4, Aug 2018. Available from: URL: http://doi.org/10.1101/mcs.a002550 - Sweden Guan J, et al. Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib. Cold Spring Harbor Molecular Case Studies 4: a002550, No. 4, Aug 2018. Available from: URL: http://​doi.​org/​10.​1101/​mcs.​a002550 - Sweden
Metadaten
Titel
Antineoplastics
Various toxicities: case report
Publikationsdatum
01.12.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-54943-4

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Methotrexate

Case report

Multiple drugs

Case report

Ofloxacin